About B-FLEXION
B-FLEXION is a Financial Services company. Investment partnerships are built and principal investments are made by B-FLEXION. It operates on a Commission-Based and Brokerage / Intermediation model in Financial Services and Healthcare sectors. B-FLEXION has completed 2 acquisitions, including Innocoll and Paratek Pharma. B-FLEXION offers products and services including Investment Partnerships, Thematic Principal Investing, B-FLEXION Life Sciences, and Service Platforms. Its focus areas include Financials, Asset Management, Investment Partnerships and Biotechnology.
Company details
Investment partnerships are seeded, acquired, and built by B-FLEXION, focusing on transformative industries. Principal investments are made in operating businesses within these sectors. Through B-FLEXION Life Sciences, targeted investments are directed towards biopharma, diagnostics, and a wide range of innovative healthcare services. Various service platforms are also developed to support investment activities across multiple domains.
- SectorsFinancial ServicesHealthcare
- Website gurnetpointcapital.com
- Social LinkedIn X
- Investments & AcquisitionsInnocoll
& 1 more
Products & Services of B-FLEXION
B-FLEXION offers a comprehensive portfolio of products and services, including Investment Partnerships, Thematic Principal Investing, B-FLEXION Life Sciences, and Service Platforms.
Partnerships are built for investment in transformative industries.
Investments are made in transformative operating business sectors.
Investments are focused on biopharma and healthcare innovations.
Platforms are developed to support various investment services.
Investments & Acquisitions by B-FLEXION
B-FLEXION has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Innocoll and Paratek Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutics for antimicrobial resistant infections are developed. | paratekpharma.com | Boston, United States | 1996 | Jun 2023 | $458.92M | |
Collagen-matrix systems for controlled drug delivery are developed in pharmaceuticals. | innocoll.com | Philadelphia, United States | 1985 | Apr 2017 | $212M |
Complete acquisition details for B-FLEXION
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of B-FLEXION
2 dated milestones of B-FLEXION across 6 years, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires Innocoll.
- Acquisition Acquires Paratek Pharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about B-FLEXION
Investment partnerships are seeded, acquired, and built by B-FLEXION, focusing on transformative industries. Principal investments are made in operating businesses within these sectors. Through B-FLEXION Life Sciences, targeted investments are directed towards biopharma, diagnostics, and a wide range of innovative healthcare services. Various service platforms are also developed to support investment activities across multiple domains.
B-FLEXION offers Investment Partnerships, Thematic Principal Investing, B-FLEXION Life Sciences, and Service Platforms.
B-FLEXION has made 2 acquisitions, including Innocoll, and Paratek Pharma.